C3 will represent people touched by colorectal cancer with the Stand Up to Cancer (SU2C) initiative by serving on the SU2C Advocacy Advisory Council. “Our role as advocates is to help shape the direction of the exciting research that will be funded by SU2C,” said Nancy Roach, C3 Board of Directors.
SU2C is a national effort to raise substantial monies for ground-breaking translational cancer research that will accelerate advances in patient care as well as in cancer prevention. A program of the Entertainment Industry Foundation, SU2C was established by a group of media, entertainment, and philanthropic leaders whose lives have all been affected by cancer in significant ways. They have partnered with American Association for Cancer Research (AACR) to provide expert scientific oversight of this important initiative.
The centerpiece of this initiative will be a nationally televised fundraising event to air on September 5, 2008. The networks have joined together in an unprecedented collaboration to donate one hour of simultaneous, commercial-free prime time for this program.
SU2C will bring together the major television networks, entertainment industry executives, celebrities and prominent leaders of the cancer research and advocacy communities to work in a way that will transcend the barriers that have traditionally inhibited creativity and collaboration. Its distinctive approach to research is designed to enable collaboration across institutions and groups by funding research projects conducted by interdisciplinary, multi-institutional, translational and clinical research “dream teams” as well as high-risk, high-impact Innovative Research Grants.
The AACR will lead the scientific review of the research projects, oversee the management of team science projects, and administer the funds raised under the direction of an expert Scientific Advisory Committee chaired by Nobel Laureate Phillip A. Sharp, Ph.D. A description of the SU2C funding model can be found here.
In addition to C3, approximately 25 other key advocacy organizations are part of the SU2C Advocate Advisory Council, which will serve as a critical resource for the project. Examples of C3’s participation include suggesting ways to enhance this national initiative and electing two members annually to serve on the Scientific Advisory Committee which will determine the funding direction and approve the research proposals. A broad description of Council members’ roles and responsibilities can be found here.
May 27, 2008 at 10:03 pm, Deborah Kanter said:
C3′s continuing commitment and resultant visibility will help cancer research, prevention, education, and change in legislation. Great news!
May 28, 2008 at 4:55 pm, Jo-Ellen said:
How wonderful. C3 is a Research-heavy colorectal cancer/Survivor group. The collective energy the Research Advocates produce should be part of this groundbreaking initiative.thank you, Nancy.
May 28, 2008 at 7:42 pm, Pam said:
I can think of nobody who can better serve in this important position. It is critical that the clinical trial system be modernized if we are to answer important questions in a timely fashion.